Please find the attached Outcome of Board meeting without Intimation dated Friday, 24th October, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Shentracon Chemicals, at its meeting on October 24, 2025, approved the appointment of Mr. Amit Lalit Jain as the Managing Director and Mr. Hanissh Kanakraj Jaain as Additional Executive Director, both effective October 24, 2025, subject to shareholder approval. The Board also appointed CA Ashish Bakliwal and Ms. Madhuri Toshniwal as Non-Executive Independent Directors for a 5-year term (October 24, 2025 to October 23, 2030). All four appointees have been confirmed as not debarred by SEBI. The MD and Executive Director appointees bring experience from the imitation jewellery, chemicals, and electroplating sectors, while the independent directors add finance, valuation, and audit expertise.
A significant board overhaul with new leadership at the top — likely a strategic refresh for the company. Shareholders will need to approve the MD and Executive Director appointments. The addition of two independent directors strengthens board composition and governance oversight.